Hao Yu
Hao Yu has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Cong Wang
School of Chinese Medicine, Bozhou University, Bozhou 236800, China
1 shared publication - Gaocheng Shi
College of Pharmacy, Anhui University of Traditional Chinese Medicine, Hefei 230012, China
1 shared publication - Gaocheng Shi
School of Chinese Medicine, Bozhou University, Bozhou 236800, China
1 shared publication - Guanglei Zhang
College of Traditional Chinese Medicine, Bozhou University, Bozhou 236800, China
1 shared publication - Huihui Meng
College of Pharmacy, Anhui University of Traditional Chinese Medicine, Hefei 230012, China
1 shared publication - Huihui Meng
School of Chinese Medicine, Bozhou University, Bozhou 236800, China
1 shared publication
Latest Publications
- Open Access
- 19 July 2026
- Published by MDPI AG in Metabolites
- Vol. 16 (7) , 506
Restoring Metabolic-Inflammatory Homeostasis: Curcumin’s Multi-Layered Defense Against Chondrocyte Dysfunction
Background: Osteoarthritis (OA) pathogenesis involves inflammatory-metabolic crosstalk driving cartilage destruction, yet the mechanisms of potential therapeutics like curcumin remain poorly defined. Methods: We integrated untargeted metabolomics, transcriptomic analysis of four GEO datasets (GSE12021, GSE55235, GSE55457, GSE82107), and three machine learning algorithms (LASSO, Random Forest, XGBoost) to characterize curcumin’s effects on IL-1β-induced human chondrocytes. Results: Metabolomic profiling demonstrated that IL-1β caused significant depletion of TCA cycle intermediates compared to blank controls, including pyruvate (log2FC = −1.34, p < 0.001) and malate (log2FC = −0.54, p < 0.001). High-dose curcumin (10 μM) significantly restored these metabolites towards normal levels (pyruvate log2FC = −0.01 vs. model; malate log2FC = −0.20 vs. model). Three machine learning algorithms converged on a six-gene inflammatory-metabolic signature (NFKBIA, MMP9, LCK, TDO2, HADHA, VEGFA), all showing excellent discriminative performance for OA (individual AUCs > 0.75). qRT-PCR validation confirmed that high-dose curcumin significantly downregulated pro-inflammatory genes compared to IL-1β treatment alone: JUN (log2FC = −0.68, p < 0.001), IL6 (log2FC = −1.13, p < 0.001), PTGS2 (log2FC = −0.94, p < 0.001), CCL20 (log2FC = −1.51, p < 0.001), and MMP9 (log2FC = −0.42, p < 0.001). Conversely, curcumin significantly upregulated the NF-κB inhibitor NFKBIA (log2FC = 0.40, p < 0.001), whose expression was initially suppressed by IL-1β (−log2FC = 0.76 vs. blank, p < 0.001). Conclusions: This systems-level analysis suggests curcumin modulates metabolic-inflammatory networks in OA chondrocytes, with NFKBIA as a candidate mediator, offering a mechanistic framework for drug-like molecule development despite curcumin’s own translational limitations.
- 19 July 2026
- Published by MDPI AG in Metabolites
- Vol. 16 (7) , 506
Open AccessRestoring Metabolic-Inflammatory Homeostasis: Curcumin’s Multi-Layered Defense Against Chondrocyte Dysfunction
Background: Osteoarthritis (OA) pathogenesis involves inflammatory-metabolic crosstalk driving cartilage destruction, yet the mechanisms of potential therapeutics like curcumin remain poorly defined. Methods: We integrated untargeted metabolomics, transcriptomic analysis of four GEO datasets (GSE12021, GSE55235, GSE55457, GSE82107), and three machine learning algorithms (LASSO, Random Forest, XGBoost) to characterize curcumin’s effects on IL-1β-induced human chondrocytes. Results: Metabolomic profiling demonstrated that IL-1β caused significant depletion of TCA cycle intermediates compared to blank controls, including pyruvate (log2FC = −1.34, p < 0.001) and malate (log2FC = −0.54, p < 0.001). High-dose curcumin (10 μM) significantly restored these metabolites towards normal levels (pyruvate log2FC = −0.01 vs. model; malate log2FC = −0.20 vs. model). Three machine learning algorithms converged on a six-gene inflammatory-metabolic signature (NFKBIA, MMP9, LCK, TDO2, HADHA, VEGFA), all showing excellent discriminative performance for OA (individual AUCs > 0.75). qRT-PCR validation confirmed that high-dose curcumin significantly downregulated pro-inflammatory genes compared to IL-1β treatment alone: JUN (log2FC = −0.68, p < 0.001), IL6 (log2FC = −1.13, p < 0.001), PTGS2 (log2FC = −0.94, p < 0.001), CCL20 (log2FC = −1.51, p < 0.001), and MMP9 (log2FC = −0.42, p < 0.001). Conversely, curcumin significantly upregulated the NF-κB inhibitor NFKBIA (log2FC = 0.40, p < 0.001), whose expression was initially suppressed by IL-1β (−log2FC = 0.76 vs. blank, p < 0.001). Conclusions: This systems-level analysis suggests curcumin modulates metabolic-inflammatory networks in OA chondrocytes, with NFKBIA as a candidate mediator, offering a mechanistic framework for drug-like molecule development despite curcumin’s own translational limitations.
- Open Access
- 29 December 2025
- Published by MDPI AG in Pharmaceuticals
- Vol. 19 (1) , 68
Network Pharmacology and Untargeted Metabolomics Analysis of the Protective Mechanisms of Total Flavonoids from Chuju in Myocardial Ischemia-Reperfusion Injury
Background/Objectives: Myocardial ischemia–reperfusion injury (MIRI) is characterized by the exacerbation of tissue damage following the restoration of blood flow to the myocardium. Chuju, recognized for its homology of food and medicine, is derived from the dried capitulum of Dendranthema morifolium (Ramat.), cultivated in Chuzhou, Anhui Province, China. Our previous studies have demonstrated that the total flavonoids extracted from Chuju (TFCJ) exhibit pharmacological efficacy against MIRI. This study will further elucidate its protective mechanism. Methods: We employed an integrative approach combining untargeted metabolomics, network pharmacology, molecular docking, and in vitro experiments to elucidate the mechanistic basis of TFCJ’s protective effects against MIRI. Results: TFCJ protected H9c2 cardiomyocytes from hypoxia/reoxygenation-induced oxidative stress and apoptosis. Integrated analyses identified Nrf2 as a central regulatory node activated by AKT signaling, which, in turn, modulates antioxidant protein expression and glutathione metabolism. Further in vitro experiments demonstrated that TFCJ induced AKT phosphorylation, thereby promoting Nrf2 activation and upregulating HO-1 expression, along with genes involved in glutathione synthesis. Conclusions: TFCJ exerts cardioprotective effects by activating the AKT-Nrf2 signaling pathway, regulating the expression of antioxidant and anti-apoptotic genes, and coordinating downstream glutathione metabolism, ultimately maintaining the oxidative-apoptotic balance in myocardial cells.
- 29 December 2025
- Published by MDPI AG in Pharmaceuticals
- Vol. 19 (1) , 68
Open AccessNetwork Pharmacology and Untargeted Metabolomics Analysis of the Protective Mechanisms of Total Flavonoids from Chuju in Myocardial Ischemia-Reperfusion Injury
Background/Objectives: Myocardial ischemia–reperfusion injury (MIRI) is characterized by the exacerbation of tissue damage following the restoration of blood flow to the myocardium. Chuju, recognized for its homology of food and medicine, is derived from the dried capitulum of Dendranthema morifolium (Ramat.), cultivated in Chuzhou, Anhui Province, China. Our previous studies have demonstrated that the total flavonoids extracted from Chuju (TFCJ) exhibit pharmacological efficacy against MIRI. This study will further elucidate its protective mechanism. Methods: We employed an integrative approach combining untargeted metabolomics, network pharmacology, molecular docking, and in vitro experiments to elucidate the mechanistic basis of TFCJ’s protective effects against MIRI. Results: TFCJ protected H9c2 cardiomyocytes from hypoxia/reoxygenation-induced oxidative stress and apoptosis. Integrated analyses identified Nrf2 as a central regulatory node activated by AKT signaling, which, in turn, modulates antioxidant protein expression and glutathione metabolism. Further in vitro experiments demonstrated that TFCJ induced AKT phosphorylation, thereby promoting Nrf2 activation and upregulating HO-1 expression, along with genes involved in glutathione synthesis. Conclusions: TFCJ exerts cardioprotective effects by activating the AKT-Nrf2 signaling pathway, regulating the expression of antioxidant and anti-apoptotic genes, and coordinating downstream glutathione metabolism, ultimately maintaining the oxidative-apoptotic balance in myocardial cells.